The world's first plant-based COVID-19 vaccine from Medicago and GSK is 75.3% effective against preventing COVID-19 of any severity (from the Delta variant), finds an NIHR-supported study.
The UK Clinical Research Recovery, Resilience and Growth Programme (RRG) has today published an update detailing the key milestones that have been achieved in the 6 months since the publication of “The Future of UK Clinical Research Delivery” 2021/22 implementation plan.
A first-of-its-kind clinical trial to investigate the effectiveness of new COVID-19 oral antiviral treatments - which can be safely taken at home - has begun enrolling participants today.
Children with poorly controlled asthma are up to six times more likely to be hospitalised with COVID-19 than those without the condition, a study conducted in Scotland suggests.
The NIHR has published its first diversity data report.
A same-day test has cut the time taken to identify secondary infections in intensive care COVID-19 patients from four days to within 24 hours.
A new NIHR-supported study is setting out to investigate why COVID-19 vaccines can lead to rare instances of blood clotting with low platelets known as thrombotic thrombocytopenia syndrome (TTS).
A new study of over 220,000 patients has found that those who contract COVID-19 are at a greater risk of fatigue and sleep problems.
Dr Jonathan Rodrigues has been awarded Outstanding Clinical Radiology Researcher of 2021 by The Royal College of Radiologists (RCR) and the NIHR.
The NIHR has awarded nearly £20 million through its global health funding programme to help tackle multiple long-term conditions.
Researchers have launched the largest ever stem cell clinical trial for children with the severe skin condition Epidermolysis Bullosa (EB) - a rare genetic condition which causes the skin to blister and tear at the slightest touch.
The CREST award was presented at the joint NIHR Clinical Research Network and Royal College of Surgeons of England research event in London yesterday.
The NIHR has announced its latest cohort of NIHR Research Professors and NIHR Global Research Professors.
The Royal College of Anaesthetists (RCoA) and NIHR Clinical Research Network Research (NIHR CRN) are pleased to announce the winners of their 2021 Awards - which recognise NHS clinicians who have made outstanding contributions to clinical research, particularly in relation to NIHR CRN portfolio studies.
A world-first study has shown that whole genome sequencing can revolutionise the diagnosis of rare diseases, improving speed and accuracy and revealing conditions other testing would miss.
The NIHR will launch new sustainability-themed package of funding for research into climate and health, NIHR Chief Executive Professor Lucy Chappell has announced at the UN Climate Change Conference (COP26).
Research by the NIHR Health Protection Research Unit in Behavioural Science and Evaluation has found that nose-swab samples to detect respiratory infections in children collected by parents, are as good as those collected by nurses.
Public access defibrillators (PADs) are disproportionately lacking in the most deprived areas of England, which are among the communities at the greatest risk of cardiac arrest, according to a new analysis led by NIHR-funded researchers.
Research funded and supported by NIHR has revealed that symptoms of irritable bowel syndrome may be caused by the same biological processes as mental health conditions such as anxiety.
Moorfields Eye Hospital NHS Foundation Trust has won the 2021 Nursing Times Award Clinical Research Nursing category, sponsored by the NIHR, for their ROAM (Research Opportunities at Moorfields) initiative.
NIHR-funded researchers have launched a new £1.98m study investigating alternative treatments in tackling MRSA in hospital patients.
The NIHR welcomes the planned £5bn investment in health-related research and development, announced today as part of the Government’s three year Spending Review.
The NIHR has awarded funding to the University of Oxford to carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use by people in the community with COVID-19 who are at higher risk of complications.
A drug used to treat agitation in people with dementia is no more effective than a placebo, and might even increase mortality, according to a new NIHR-funded study.
An NIHR-supported study investigating Valneva’s COVID-19 vaccine candidate has reported positive results - with participants who received the VLA2001 vaccine generating high levels of neutralising antibodies against the disease.
